Ca2+/calmodulin-stimulated PDE1 regulates the beta-catenin/TCF signaling through PP2A B56 gamma subunit in proliferating vascular smooth muscle cells

FEBS Journal

Volumn 277, Issue 24, 2010, Pages 5026-5039

  Jeon, Kye Im ^a   Jono, Hirofumi ^a   Miller, Clint L ^a   Cai, Yujun ^a   Lim, Soyeon ^a   Liu, Xuan ^b   Gao, Pingjin ^c   Abe, Jun Ichi ^a   Li, Jian Dong ^a   Yan, Chen ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

catenin; cyclic nucleotide; phosphodiesterase; PP2A; vascular smooth muscle cells

Indexed keywords

BETA CATENIN; GLYCOGEN SYNTHASE KINASE 3BETA; PHOSPHODIESTERASE I; PHOSPHOPROTEIN PHOSPHATASE 2A; PHOSPHOPROTEIN PHOSPHATASE 2A B56 GAMMA; T CELL FACTOR PROTEIN; UNCLASSIFIED DRUG; CALCIUM; CALMODULIN; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE 1; GLYCOGEN SYNTHASE KINASE 3; PHOSPHOPROTEIN PHOSPHATASE 2;

ANIMAL CELL; ARTICLE; CELL FUNCTION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; GENE EXPRESSION REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; UPREGULATION; VASCULAR SMOOTH MUSCLE; ANIMAL; CELL CULTURE; CYTOLOGY; ENZYMOLOGY; GENETIC TRANSCRIPTION; METABOLISM; PHOSPHORYLATION;

ANIMALS; BETA CATENIN; CALCIUM; CALMODULIN; CELL PROLIFERATION; CELLS, CULTURED; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 1; ENZYME ACTIVATION; GLYCOGEN SYNTHASE KINASE 3; MUSCLE, SMOOTH, VASCULAR; PHOSPHORYLATION; PROTEIN PHOSPHATASE 2; RATS; TCF TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 78650018621     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2010.07908.x     Document Type: Article

References (48)

1. Wang X, Xiao Y, Mou Y, Zhao Y, Blankesteijn WM, &, Hall JL, (2002) A role for the betaβ-catenin/T-cell factor signaling cascade in vascular remodeling. Circ Res 90, 340-347.
2. Slater SC, Koutsouki E, Jackson CL, Bush RC, Angelini GD, Newby AC, &, George SJ, (2004) R-cadherin:betaβ-catenin complex and its association with vascular smooth muscle cell proliferation. Arterioscler Thromb Vasc Biol 24, 1204-1210.
3. Quasnichka H, Slater SC, Beeching CA, Boehm M, Sala-Newby GB, &, George SJ, (2006) Regulation of smooth muscle cell proliferation by betaβ-catenin/T-cell factor signaling involves modulation of cyclin D1 and p21 expression. Circ Res 99, 1329-1337.
4. Dwivedi A, Slater SC, &, George SJ, (2009) MMP-9 and -12 cause N-cadherin shedding and thereby betaβ-catenin signalling and vascular smooth muscle cell proliferation. Cardiovasc Res 81, 178-186.
5. Goodwin AM, &, D'Amore PA, (2002) Wnt signaling in the vasculature. Angiogenesis 5, 1-9.
6. Couffinhal T, Dufourcq P, &, Duplaa C, (2006) Betaβ-catenin nuclear activation: common pathway between Wnt and growth factor signaling in vascular smooth muscle cell proliferation? Circ Res 99, 1287-1289.
7. Novak A, &, Dedhar S, (1999) Signaling through betaβ-catenin and Lef/Tcf. Cell Mol Life Sci 56, 523-537.
8. Roose J, &, Clevers H, (1999) TCF transcription factors: molecular switches in carcinogenesis. Biochim Biophys Acta 1424, M23-M37.
9. Liu J, Stevens J, Rote CA, Yost HJ, Hu Y, Neufeld KL, White RL, &, Matsunami N, (2001) Siah-1 mediates a novel betaβ-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein. Mol Cell 7, 927-936.
10. Takemaru K, Fischer V, &, Li FQ, (2009) Fine-tuning of nuclear β-catenin by chibby and 14-3-3. Cell Cycle 8, 210-213.
11. Shitashige M, Hirohashi S, &, Yamada T, (2008) Wnt signaling inside the nucleus. Cancer Sci 99, 631-637.
12. Daugherty RL, &, Gottardi CJ, (2007) Phospho-regulation of Betaβ-catenin adhesion and signaling functions. Physiology (Bethesda) 22, 303-309.
13. Zolnierowicz S, (2000) Type 2A protein phosphatase, the complex regulator of numerous signaling pathways. Biochem Pharmacol 60, 1225-1235.
14. Janssens V, &, Goris J, (2001) Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem J 353, 417-439.
15. Bender AT, &, Beavo JA, (2006) Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol Rev 58, 488-520.
16. 2+/calmodulin- stimulated phosphodiesterase 1A in vascular smooth muscle cell growth and survival. Circ Res 98, 777-784.
17. 2+/calmodulin- stimulated cyclic nucleotide phosphodiesterase 1 in mediating cardiomyocyte hypertrophy. Circ Res 105, 956-964.
18. Bender AT, &, Beavo JA, (2006) PDE1B2 regulates cGMP and a subset of the phenotypic characteristics acquired upon macrophage differentiation from a monocyte. Proc Natl Acad Sci USA 103, 460-465.
19. Rybalkin SD, Rybalkina I, Beavo JA, &, Bornfeldt KE, (2002) Cyclic nucleotide phosphodiesterase 1C promotes human arterial smooth muscle cell proliferation. Circ Res 90, 151-157.
20. Han P, Werber J, Surana M, Fleischer N, &, Michaeli T, (1999) The calcium/calmodulin-dependent phosphodiesterase PDE1C down-regulates glucose-induced insulin secretion. J Biol Chem 274, 22337-22344.
21. Dunkern TR, &, Hatzelmann A, (2007) Characterization of inhibitors of phosphodiesterase 1C on a human cellular system. FEBS J 274, 4812-4824.
22. Cohen P, &, Frame S, (2001) The renaissance of GSK3β. Nat Rev Mol Cell Biol 2, 769-776.
23. McCright B, Rivers AM, Audlin S, &, Virshup DM, (1996) The B56 family of protein phosphatase 2A (PP2A) regulatory subunits encodes differentiation-induced phosphoproteins that target PP2A to both nucleus and cytoplasm. J Biol Chem 271, 22081-22089.
24. Tehrani MA, Mumby MC, &, Kamibayashi C, (1996) Identification of a novel protein phosphatase 2A regulatory subunit highly expressed in muscle. J Biol Chem 271, 5164-5170.
25. Gigena MS, Ito A, Nojima H, &, Rogers TB, (2005) A B56 regulatory subunit of protein phosphatase 2A localizes to nuclear speckles in cardiomyocytes. Am J Physiol Heart Circ Physiol 289, H285-H294.
26. Aizawa T, Wei H, Miano JM, Abe J, Berk BC, &, Yan C, (2003) Role of phosphodiesterase 3 in NO/cGMP-mediated antiinflammatory effects in vascular smooth muscle cells. Circ Res 93, 406-413.
27. Lechward K, Awotunde OS, Swiatek W, &, Muszynska G, (2001) Protein phosphatase 2A: variety of forms and diversity of functions. Acta Biochim Pol 48, 921-933.
28. 2+ channels in human vascular smooth-muscle cells. Biochem J 318, 513-517.
29. Azzi A, Aratri E, Boscoboinik D, Clement S, Ozer NK, Ricciarelli R, &, Spycher S, (1998) Molecular basis of alpha-tocopherol control of smooth muscle cell proliferation. Biofactors 7, 3-14.
30. Campbell M, Anderson P, &, Trimble ER, (2008) Glucose lowers the threshold for human aortic vascular smooth muscle cell migration: inhibition by protein phosphatase-2A. Diabetologia 51, 1068-1080.
31. Yellaturu CR, Bhanoori M, Neeli I, &, Rao GN, (2002) N-Ethylmaleimide inhibits platelet-derived growth factor BB-stimulated Akt phosphorylation via activation of protein phosphatase 2A. J Biol Chem 277, 40148-40155.
32. Yamashita M, Dimayuga P, Kaul S, Shah PK, Regnstrom J, Nilsson J, &, Cercek B, (1999) Phosphatase activity in the arterial wall after balloon injury: effect of somatostatin analog octreotide. Lab Invest 79, 935-944.
33. Rybalkin SD, Bornfeldt KE, Sonnenburg WK, Rybalkina IG, Kwak KS, Hanson K, Krebs EG, &, Beavo JA, (1997) Calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1C) is induced in human arterial smooth muscle cells of the synthetic, proliferative phenotype. J Clin Invest 100, 2611-2621.
34. Jiang X, Li J, Paskind M, &, Epstein PM, (1996) Inhibition of calmodulin-dependent phosphodiesterase induces apoptosis in human leukemic cells. Proc Natl Acad Sci USA 93, 11236-11241. (Pubitemid 26333147)
35. Thompson WJ, Piazza GA, Li H, Liu L, Fetter J, Zhu B, Sperl G, Ahnen D, &, Pamukcu R, (2000) Exisulind induction of apoptosis involves guanosine 3′,5′-cyclic monophosphate phosphodiesterase inhibition, protein kinase G activation, and attenuated betaβ-catenin. Cancer Res 60, 3338-3342.
36. Liu L, Li H, Underwood T, Lloyd M, David M, Sperl G, Pamukcu R, &, Thompson WJ, (2001) Cyclic GMP-dependent protein kinase activation and induction by exisulind and CP461 in colon tumor cells. J Pharmacol Exp Ther 299, 583-592.
37. Li H, Pamukcu R, &, Thompson WJ, (2002) beta-Catenin signaling: therapeutic strategies in oncology. Cancer Biol Ther 1, 621-625.
38. Yan C, Nagel DJ, &, Jeon KI, (2007) Regulation and function of cyclic nucleotide phosphodiesterases in vascular smooth muscle and vascular diseases. In Cyclic Nucleotide Phosphodiesterases in Health and Disease (, Beavo J, Francis SH, &, Houslay MD, eds), pp 465-484. CRC Press, Boca Raton, FL.
39. Chiu PJ, Tetzloff G, Ahn HS, &, Sybertz EJ, (1988) Comparative effects of vinpocetine and 8-Br-cyclic GMP on the contraction and 45Ca-fluxes in the rabbit aorta. Am J Hypertens 1, 262-268.
40. Ahumada A, Slusarski DC, Liu X, Moon RT, Malbon CC, &, Wang HY, (2002) Signaling of rat Frizzled-2 through phosphodiesterase and cyclic GMP. Science 298, 2006-2010.
41. 2+/cGMP-signalling pathway in development. Biochem Soc Trans 32, 792-796.
42. 2+ pathway. J Biol Chem 281, 30990-31001.
43. 2+, and cyclic GMP: visualizing Frizzled functions. Science 300, 1529-1530.
44. Kang DE, Soriano S, Xia X, Eberhart CG, De Strooper B, Zheng H, &, Koo EH, (2002) Presenilin couples the paired phosphorylation of betaβ-catenin independent of axin: implications for betaβ-catenin activation in tumorigenesis. Cell 110, 751-762.
45. Hino S, Tanji C, Nakayama KI, &, Kikuchi A, (2005) Phosphorylation of betaβ-catenin by cyclic AMP-dependent protein kinase stabilizes betaβ-catenin through inhibition of its ubiquitination. Mol Cell Biol 25, 9063-9072.
46. Pekkinen M, Ahlstrom ME, Riehle U, Huttunen MM, &, Lamberg-Allardt CJ, (2008) Effects of phosphodiesterase 7 inhibition by RNA interference on the gene expression and differentiation of human mesenchymal stem cell-derived osteoblasts. Bone 43, 84-91.
47. Shouse GP, Cai X, &, Liu X, (2008) Serine 15 phosphorylation of p53 directs its interaction with B56gamma and the tumor suppressor activity of B56gamma-specific protein phosphatase 2A. Mol Cell Biol 28, 448-456.
48. Melkonyan H, Sorg C, &, Klempt M, (1996) Electroporation efficiency in mammalian cells is increased by dimethyl sulfoxide (DMSO). Nucleic Acids Res 24, 4356-4357.